ClinicalTrials.govpublic full text
A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults
respiratory synctial virus infections, reactogenicity, safety, respiratory syncytial virus (rsv), vaccine, immunogenicity, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 864729
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.